Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey

Total article views   HTML views PDF downloads Totals
12,333 Dovepress* 10,969+ 1,785 12,754
PubMed Central* 1,364 565 1,929
Totals 12,333 2,350 14,683
*Since 23 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar